Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRSN | AMGN | VRTX | REGN | BMY |
| Company | Mersana Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 2.71 | 314.41 | 444.72 | 980.42 | 44.00 |
| High | 2.78 | 315.81 | 447.85 | 987.99 | 44.04 |
| Low | 2.67 | 312.62 | 442.98 | 978.21 | 43.31 |
| Last | 2.77 | 314.54 | 445.87 | 987.27 | 43.36 |
| Change | +0.04 | +2.07 | +0.66 | +4.98 | -0.67 |
| % Change | +1.47% | +0.66% | +0.15% | +0.51% | -1.52% |
| Volume | 838,600 | 1,394,700 | 742,200 | 317,800 | 10,376,800 |
| 20-Day Average Volume | 1,925,950 | 2,872,410 | 1,089,800 | 454,140 | 15,093,370 |
| Previous Close | 2.73 | 312.47 | 445.21 | 982.29 | 44.03 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.99 | 295.70 | 414.71 | 943.62 | 44.75 |
| 20-Day Raw Stochastic | 27.12% | 85.83% | 96.47% | 98.51% | 0.81% |
| 20-Day Relative Strength | 38.92% | 64.64% | 72.35% | 62.19% | 31.49% |
| Weighted Alpha | +3.82 | +42.40 | +36.13 | +35.48 | -33.88 |
| Today's Opinion | 8% Sell | 72% Buy | 72% Buy | 100% Buy | 100% Sell |
| Previous Opinion | 8% Sell | 72% Buy | 72% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 24% Buy | 56% Sell | 8% Buy | 24% Buy | 72% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.73% since 05/13/24 | +1.97% since 05/13/24 | +3.71% since 05/13/24 | +1.06% since 05/13/24 | -3.77% since 05/13/24 |
| Low | 2.45 on 05/14/24 | 307.47 on 05/14/24 | 422.44 on 05/14/24 | 966.00 on 05/17/24 | 43.31 on 05/20/24 |
| High | 2.88 on 05/15/24 | 321.44 on 05/15/24 | 447.85 on 05/20/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | -14.77% since 04/19/24 | +16.96% since 04/19/24 | +13.08% since 04/19/24 | +10.09% since 04/19/24 | -11.38% since 04/19/24 |
| Low | 2.45 on 05/14/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.31 on 05/20/24 |
| High | 3.63 on 05/07/24 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | -23.69% since 02/20/24 | +10.94% since 02/20/24 | +6.00% since 02/20/24 | +4.27% since 02/20/24 | -13.04% since 02/20/24 |
| Low | 2.45 on 05/14/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.31 on 05/20/24 |
| High | 6.28 on 03/11/24 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +73.13% since 11/20/23 | +18.54% since 11/20/23 | +24.95% since 11/20/23 | +23.16% since 11/20/23 | -11.33% since 11/20/23 |
| Low | 1.47 on 12/01/23 | 260.52 on 11/21/23 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 43.31 on 05/20/24 |
| High | 6.28 on 03/11/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 338,940 | 168,730,256 | 115,058,088 | 108,783,320 | 87,895,056 |
| Shares Outstanding, K | 122,361 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 36,860,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -171,670,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 9,250,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -19,310,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 1.61 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 05/09/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.77 | 29.56 | 26.47 | 41.93 |